Journal of Clinical Oncology, Vol 10, 1822, Copyright © 1992 by American Society of Clinical Oncology
Patterns of Treatment Failure and Prognostic Factors Associated With the Treatment of Esophageal Carcinoma With Chemotherapy and Radiotherapy Either as Sole Treatment or Followed by Surgery
Peter G. Gill ,
Jim W. Denham ,
Glyn G. Jamieson ,
Peter G. Devitt ,
Eric Yeoh , ,
Charles Olweny
The dosage of fluorouracil printed in the abstract of the report by Gill et al, "Patterns and Treatment Failure and Prognostic Factors Associated With the Treatment of Esophageal Carcinoma With Chemotherapy and Radiotherapy Either as Sole Treatment or Followed by Surgery" (J Clin Oncol 10:10371043, 1992), should have been 800 mg/m2 as stated elsewhere in the report.
The unit of measure for interleukin-2 and Interferon alfa-2a in the report by Ilson et al, "A Phase II Trial of Interleukin-2 and Interferon Alfa-2a in Patients With Advanced Renal Cell Carcinoma" (J Clin Oncol 10:11241130, 1992), should have been "U/m2d," not "µ/m2/d."